0001104659-22-001644.txt : 20220105
0001104659-22-001644.hdr.sgml : 20220105
20220105194412
ACCESSION NUMBER: 0001104659-22-001644
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Mark K.
CENTRAL INDEX KEY: 0001786183
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39202
FILM NUMBER: 22513192
MAIL ADDRESS:
STREET 1: 227 7TH AVENUE NE
CITY: ST. PETERSBURG
STATE: FL
ZIP: 33701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annovis Bio, Inc.
CENTRAL INDEX KEY: 0001477845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262540421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
BUSINESS PHONE: 610-727-3913
MAIL ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
FORMER COMPANY:
FORMER CONFORMED NAME: QR Pharma, Inc.
DATE OF NAME CHANGE: 20091202
4
1
tm221949-6_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-03
0
0001477845
Annovis Bio, Inc.
ANVS
0001786183
White Mark K.
C/O ANNOVIS BIO, INC.
1055 WESTLAKES DRIVE, SUITE 300
BERWYN
PA
19312
1
0
0
0
Stock Option (right to buy)
19.78
2022-01-03
4
A
0
8000
0
A
2032-01-03
Common Stock
8000
8000
D
The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.
/s/ Jeffrey McGroarty, Attorney-in-Fact for Mark White
2022-01-05